1. All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

   • Richard F. Schlenk
   • Michael Lübbert
   • for the German-Austrian Acute Myeloid Leukemia Study Group

   Original Article Open access 03 October 2016 Pages: 1931 - 1942

   

2. Familial hematological malignancies: new IDH2 mutation

   • Walid-Sabri Hamadou
   • Violaine Bourdon
   • Zohra Soua

   Original Article 03 September 2016 Pages: 1943 - 1947

   

3. CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemia

   • Jordi Juncà
   • Olga Garcia
   • Fuensanta Millá

   Original Article 05 September 2016 Pages: 1949 - 1954

   

4. Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel)

   • Chiara Cattaneo
   • P. Zappasodi
   • G. Rossi

   Original Article 21 September 2016 Pages: 1955 - 1963

5. CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis

   • Claudia Augello
   • Daniele Cattaneo
   • Umberto Gianelli

   Original Article 05 September 2016 Pages: 1965 - 1969

   

6. Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

   • E. M. P. Cremers
   • A. van Biezen
   • T. de Witte

   Original Article Open access 20 September 2016 Pages: 1971 - 1978

   

7. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia

   • Andrea Haerzschel
   • Julie Catusse
   • Meike Burger

   Original Article Open access 20 August 2016 Pages: 1979 - 1988

   

8. Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia

   • Eleshia J. Morrison
   • Joseph M. Flynn
   • Barbara L. Andersen

   Original Article 19 August 2016 Pages: 1989 - 1997

   

9. Detection of the value of consecutive serum total light chain (sTLC) in patients diagnosed with diffuse large B cell lymphoma

   • Linzhu Zhai
   • Yuanyuan Zhao
   • Lizhu Lin

   Original Article 14 September 2016 Pages: 1999 - 2007

   

10. Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia

    • Samantha N. Reiss
    • Larry W. Buie
    • Dan Douer

    Original Article 20 August 2016 Pages: 2009 - 2015

    

11. Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era

    • Sayako Yuda
    • Dai Maruyama
    • Kensei Tobinai

    Original Article Open access 26 September 2016 Pages: 2017 - 2022

    

12. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome

    • Jing Jia
    • Yuqin Song
    • Jun Zhu

    Original Article 06 September 2016 Pages: 2023 - 2031

    

13. Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials

    • Maria-Victoria Mateos
    • Albert Oriol
    • Jesus San Miguel

    Original Article 14 October 2016 Pages: 2033 - 2041

    

14. The impact of H63D HFE gene carriage on hemoglobin and iron status in children

    • Kaczorowska-Hac Barbara
    • Luszczyk Marcin
    • Kaczor Jan Jacek

    Original Article Open access 24 August 2016 Pages: 2043 - 2048

    

15. The impact of postpartum hemoglobin levels on maternal quality of life after delivery: a prospective exploratory study

    • C. M. Miller
    • B. Ramachandran
    • Alexander J. Butwick

    Original Article 13 September 2016 Pages: 2049 - 2055

16. Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters

    • Mohammad Refaei
    • Bruna Fernandes
    • Cynthia Wu

    Original Article 20 August 2016 Pages: 2057 - 2064

    

17. How can we help haematological cancer survivors cope with the changes they experience as a result of their cancer?

    • Alix Hall
    • Marita Lynagh
    • Jamie Bryant

    Original Article 13 September 2016 Pages: 2065 - 2076

18. Improvement in hereditary hemorrhagic telangiectasia after treatment with the multi-kinase inhibitor Sunitinib

    • Freya Droege
    • Kruthika Thangavelu
    • Urban Geisthoff

    Letter to the Editor 15 August 2016 Pages: 2077 - 2078

19. Isolated thrombocytopenia and liver function abnormalities characterizing an atypical presentation of thrombotic thrombocytopenic purpura

    • Rajat Bansal
    • Maria R. Baer
    • Jennie Y. Law

    Letter to the Editor 20 August 2016 Pages: 2079 - 2080

20. Acute monocytic leukemia masked by hemolytic anemia and sclerotic lesions

    • Michael Sze Yuan Low
    • Shahla Vilcassim
    • George Grigoriadis

    Letter to the Editor 30 August 2016 Pages: 2081 - 2082

    

21. End-of-treatment FDG-PET lacks usefulness in Hodgkin lymphoma

    • Hugo J. A. Adams
    • Thomas C. Kwee

    Letter to the Editor 03 September 2016 Pages: 2083 - 2084

22. No convincing evidence to support postinduction FDG-PET in follicular lymphoma

    • Hugo J. A. Adams
    • Thomas C. Kwee

    Letter to the Editor 08 September 2016 Pages: 2085 - 2086

23. Therapeutic drug monitoring enables safe and effective lenalidomide therapy in patients with multiple myeloma on hemodialysis

    • Takahiro Kobayashi
    • Takenori Niioka
    • Naoto Takahashi

    Letter to the Editor 06 September 2016 Pages: 2087 - 2088

    

24. Effects of low-dose thalidomide in chronic refractory immune thrombocytopenia and contributions to the dispensation of glucocorticoid dependence

    • Yafei Yin
    • Mingyang Deng
    • Guangsen Zhang

    Letter to the Editor 03 September 2016 Pages: 2089 - 2090

    

25. Acquired protein S deficiency manifests as pulmonary embolism in early pregnancy: a case report

    • Kristina Gvozdjan
    • Ruth Juodikis
    • Vladimir Vidanovic

    Letter to the Editor 06 September 2016 Pages: 2091 - 2092

26. Attempted suicide with rivaroxaban

    • Dorit Blickstein
    • Saaid Younes
    • Sigal Nakav

    Letter to the Editor 14 September 2016 Pages: 2093 - 2094

27. Linezolid-associated reticulocytopenia

    • Danielle H. Oh
    • Olga Motorna
    • Michael Gilbertson

    Letter to the Editor 23 September 2016 Pages: 2095 - 2097

    

28. Acquired hemophilia A in a patient with hepatocellular carcinoma: a case report and literature review

    • A. I. Franco-Moreno
    • M. Santero-García
    • M. J. García-Navarro

    Letter to the Editor 26 September 2016 Pages: 2099 - 2100

29. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene

    • Joana Maria Saraiva Diamond
    • António Medina de Almeida
    • Manuel Maria de Sousa Ferreira Abecasis

    Letter to the Editor 03 October 2016 Pages: 2101 - 2104

    

30. Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

    • Hampig Raphael Kourie
    • Lieveke Ameye
    • Dominique Bron

    Letter to the Editor 29 September 2016 Pages: 2105 - 2106

31. Acknowledgement to referees

    ACKNOWLEDGEMENT TO REFEREES 02 November 2016 Pages: 2107 - 2110